FTC approves final order imposing conditions on Stryker Corp.’s acquisition of Wright Medical
Topics: STRYKER WRIGHT MEDICAL
According to the complaint, which was first announced in November 2020, the proposed acquisition would likely result in substantial competitive harm to consumers in the U.S. markets for total ankle replacements and finger joint implants.
The final order requires Stryker and Wright to divest all assets associated with Stryker’s total ankle replacements and finger joint implants to DJO Global, allowing it to become an independent, viable, and effective competitor in these markets. The Commission vote to approve the final order was 5-0. ■